Primaquine pharmacokinetics in lactating women and breastfed infant exposures
Primaquine is the only drug providing radical cure of Plasmodium vivax malaria. It is not recommended for breastfeeding women as it causes hemolysis in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals, and breast milk excretion and thus infant exposure are not known.Healthy G6PD normal...
Autors principals: | Gilder, M, Hanpithakphong, W, Hoglund, R, Tarning, J, Win, H, Hilda, N, Chu, C, Bancone, G, Carrara, V, Singhasivanon, P, White, N, Nosten, F, McGready, R |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
Oxford University Press
2018
|
Ítems similars
-
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants
per: Wattanakul, T, et al.
Publicat: (2024) -
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants
per: Thanaporn Wattanakul, et al.
Publicat: (2024-05-01) -
Mechanistic modeling of primaquine pharmacokinetics, gametocytocidal activity, and mosquito infectivity
per: Chotsiri, P, et al.
Publicat: (2022) -
Pharmacokinetic interactions between primaquine and chloroquine.
per: Pukrittayakamee, S, et al.
Publicat: (2014) -
Antimalarial drugs for treating and preventing malaria in pregnant and lactating women
per: Saito, M, et al.
Publicat: (2018)